 A 2005 phase-3 clinical trial called "SAINT-1" reported some efficacy in the acute treatment of ischemia injury due to stroke.However, a 2006 attempt to repeat this trial indicated no significant activity.After ruling out other causes, the authors tentatively attributed the positive results in the first trial to "chance".